Back to search
Thromboembolic Disease Recurrent
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Thromboembolic Disease Recurrent trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Thromboembolic Disease Recurrent trials you may qualify forThis study is being done to determine the feasibility and safety of using a novel dose adjusted apixaban for the management of participants with cancer-associat…
The main objective of the BREIZH-Cohorte study is to determine the incidence of recurrent short, medium and long-term thromboembolic venous disease as well as r…
This prospective, single-arm observational cohort study aims to evaluate the real-world effectiveness and safety of direct oral anticoagulants (DOACs), specific…
Venous thromboembolic disease is a common pathology in the general population (1.5/1000), the prognosis of which depends in particular on the risk of recurrence…
The objective of this study is to prospectively develop a risk assessment model (RAM) that accurately identifies anticoagulated cancer-associated thrombosis (CA…
The study aims at optimizing extended management of elderly patients (\> 75 years) with at least one of the known bleeding risk factor, who suffered from first…
This study is a prospective, multicenter international trial aimed at assessing the actual incidence, identifying associated factors, and evaluating the clinica…
Patients with a history of blood clots are at risk of developing additional clots in the future. Doctors use a tool called a clinical decision rule to tell them…
The main research question of this study is to obtain further safety and effectiveness data on Pradaxa Pellets in children aged 3 months to less than 12 years i…